Sera Prognostics
Latest round
- Series E
Last raised
- Feb 2021
Total raised
- $178M
Investors
- 14
About Sera Prognostics
Based in Utah, US, Sera Prognostics, Inc. was founded in 2008 by co-founders Dennis Farrar, Sean Esplin, and Steven Graves. Dr. Critchfield became the CEO of the company in November 2011. As of 2021, Sera Prognostics has 74 employees.69 million shares at USD 16 per share on the NASDAQ. Sera Prognostics, Inc. provides the PreTRM® Test, a pregnancy testing kit that predicts early preterm birth risk of pregnancy complications and helps pregnant women and doctors to understand the potential pregnancy risk. The firm's platform uses proprietary biomarkers that are predictive of preterm birth, preeclampsia, and other pregnancy complications. Sera Prognostics, Inc.
Who invested in Sera Prognostics
14 investors across 7 rounds
See all investors in Sera Prognostics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series E
Feb 23, 2021
Amount
$62M
Investors
Series D
Jul 31, 2019
Amount
$26M
Investors
Series C
Jan 10, 2017
Amount
$40M
Investors
Series B
Jan 7, 2015
Amount
$25M
Investors
Series B
Nov 18, 2014
Amount
$5M
Investors
Series A
Nov 15, 2011
Amount
$19M
Investors
Series A
Jan 4, 2011
Amount
$1.4M
Investors
Questions about Sera Prognostics
Who invested in Sera Prognostics?
Sera Prognostics has 14 investors on record across 7 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Sera Prognostics raised?
Sera Prognostics has raised 7 venture rounds. Sign up free to see how much each round raised and the total.
When did Sera Prognostics last raise money?
Sera Prognostics's most recent round on record is a Series E, in Feb 2021.
What does Sera Prognostics do?
Based in Utah, US, Sera Prognostics, Inc.
Where is Sera Prognostics headquartered?
Sera Prognostics is headquartered in Salt Lake City, US.
Which VCs invest in companies like Sera Prognostics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back medical devices & equipment companies at Sera Prognostics's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series E
Raising like Sera Prognostics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.